行情

ARMP

ARMP

Armata Pharmaceuticals Inc
AMEX

实时行情|Nasdaq Last Sale

3.200
-0.080
-2.44%
已收盘, 16:00 04/07 EDT
开盘
3.300
昨收
3.280
最高
3.390
最低
3.120
成交量
1.90万
成交额
--
52周最高
6.92
52周最低
2.450
市值
3,496.65万
市盈率(TTM)
-1.3804
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测ARMP价格均价为8.75,最高价位9.00,最低价为8.00。

EPS

ARMP 新闻

更多
  • Facebook面向情侣发布新聊天应用 可记录爱情时间线
  • 新浪科技 · 14分钟前
  • Twitter创始人宣布捐献10亿美元抗击新冠病毒
  • 新浪科技 · 58分钟前
  • 特朗普:美国将研究暂扣为世卫组织提供的资金
  • 新浪美股 · 1小时前
  • 隔夜要闻:道指回吐逾900点涨幅 美油下挫逾9%
  • 新浪美股 · 1小时前

所属板块

生物技术和医学研究
-2.89%
制药与医学研究
-0.82%

热门股票

代码
价格
涨跌幅

ARMP 简况

Armata Pharmaceuticals, Inc., formerly AmpliPhi Biosciences Corporation, is a biotechnology company. The Company is focused on the discovery, development and commercialization of phage therapeutics. The Company is engaged in identifying, characterizing and developing naturally occurring bacteriophages with its collaboration partners in bacteriophage biology, synthetic biology and manufacturing, to develop second-generation bacteriophage products. The Company is engaged in developing these phage product candidates using a discovery and development platform, which is designed for identification, characterization and manufacturing of multiple phage therapies. Each product candidate combines several chosen phages, which target a specific disease-causing bacterial pathogen, such as staphylococcus aureus (S. aureus), Pseudomonas aeruginosa (P. aeruginosa) and clostridium difficile (C. difficile). Its product candidates are AB-SA01 and AB-PA01.
展开

微牛提供Armata Pharmaceuticals Inc(AMEX-ARMP)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的ARMP股票新闻,以帮助您做出投资决策。